Your browser doesn't support javascript.
loading
Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.
Suleiman, Yaman; Dalia, Samir; Liu, Jane Jijun; Bowers, Jeremy W; Padron, Eric; Lancet, Jeffrey E; Fulp, William; Moscinski, Lynn C; Komrokji, Rami S; Zuckerman, Kenneth S; Zhang, Ling.
Afiliação
  • Suleiman Y; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
  • Dalia S; Mercy Clinic Oncology and Hematology Joplin, Joplin, MO, United States.
  • Liu JJ; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
  • Bowers JW; Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
  • Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
  • Lancet JE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
  • Fulp W; Department of Biostatistics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
  • Moscinski LC; Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
  • Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
  • Zuckerman KS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
  • Zhang L; Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States. Electronic address: ling.zhang@moffitt.org.
Leuk Res ; 42: 52-8, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26894965
Transformation of essential thrombocythemia (ET) to myelodysplastic syndromes or acute myeloid leukemia is infrequent, comprising 1-5% of cases with dismal clinical outcome. Studies on prognosis in ET patients with leukemic transformation are limited. The large cohort included 40 patients (1990-2014) with ET transformation (median age of 59 years, M:F of 1:1). Median time from ET diagnosis to transformation was 76 months (26-481) with median follow-up time of 15 years. Advanced age, myelofibrosis (grade 2-3), and leukocytosis at the time of transformation were associated with inferior OS from transformation (p<0.05). Given rarity of the clinical scenario, multicenter efforts are encouraged.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transformação Celular Neoplásica / Trombocitemia Essencial Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transformação Celular Neoplásica / Trombocitemia Essencial Idioma: En Ano de publicação: 2016 Tipo de documento: Article